Holding(s) In Company
Acme Investments SPF Sarl, through Timo Syrjälä, has reduced its holding in Faron Pharmaceuticals Ltd to 7.77% of voting rights, representing 15,509,433 shares, down from a previous holding of 12.69%. This change, effective April 15, 2026, is due to an acquisition or disposal of voting rights and an event changing the breakdown of voting rights, specifically related to dividend payments in kind and a Faron share issue in April 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | April 16, 2026 at 18:00:00 EEST |
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
TR-1: Standard form for notification of major holdings
- Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
| Non-UK issuer | x |
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
| An acquisition or disposal of voting rights | x |
| An acquisition or disposal of financial instruments | |
| An event changing the breakdown of voting rights | x |
Other (please specify) iii : Dividend payments in kind.
Details of person subject to the notification obligation iv
| Name | Timo Syrjälä |
| City and country of registered office (if applicable) | Monaco |
Full name of shareholder(s) (if different from 3.) v
| Name | Acme Investments SPF Sarl |
|---|---|
| City and country of registered office (if applicable) | Luxembourg |
| 5. Date on which the threshold was crossed or reached vi : | 15.4.2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 16.4.2026 |
- Total positions of person(s) subject to the notification obligation
| Name | Acme Investments SPF Sarl | |||
|---|---|---|---|---|
| City and country of registered office (if applicable) | Luxembourg | |||
| Resulting situation on the date on which threshold was crossed or reached | 7.77% | 15.509.433 | ||
| Position of previous notification (if applicable) | 12.69% | 14.697.112 | ||
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| FI4000153309 | 5.949.320 | 9.560.113 | 2.98% | 4.79% |
| SUBTOTAL 8. A | 15.509.433 | 7.77% | ||
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Timo Syrjälä (Direct) | 2.98% | 2.98% |
| Acme Investments SPF Sarl (Indirect) | 4.79% | 4.79% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information Faron share issue during April 2026
| Place of completion | Monaco |
|---|---|
| Date of completion | 16.4.2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.